Business Wire

MA-ALIRA-HEALTH

Share
Alira Health Secures an Additional $40M in Funding, Led by Creadev

Alira Health (www.alirahealth.com ), a global technology-enabled healthcare consultancy, announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. Alira Health intends to use the funds to invest in solutions that actively engage patients in the delivery of services for healthcare providers, payers, and suppliers. The financing was provided by key existing investors Creadev, an evergreen investment company backed by the Mulliez family of France.

“Alira Health’s mission is to humanize healthcare. We are extremely pleased to have the support of our investors who share our vision of putting patients at the center of healthcare transformation and innovation,” said Gabriele Brambilla, CEO and Co-Founder of Alira Health. “This investment positions us to lead the market for delivering services using data collected directly from patients on digital health platforms. Our clients will have a clear advantage in developing and commercializing products by using patient-provided data to inform every stage of their product life cycle continuum.”

“We continue to be impressed with Alira Health’s strategy and growth,” said Yohann Gbahoué, Healthcare Managing Director, Creadev. “Alira Health’s vision of patient-centric health care innovation, coupled with their ability to deliver on this promise, is truly revolutionary. We commend Alira Health on its transformational acquisitions and look forward to supporting the firm’s organic and inorganic growth.”

About Creadev:

Creadev is an evergreen investment firm operating worldwide, controlled by the Mulliez family, founders of one of the largest Business to Consumer retail platforms in the world. Creadev is committed to long-term collaboration with innovative, passionate, and human-driven entrepreneurs that are focused on creating widespread access to essential goods and services such as healthcare, sustainable consumption, and food. Based in Paris, and with offices in New-York, Shanghai and Nairobi, Creadev invests in companies well positioned to scale and become worldwide leaders in their respective sectors. Launched in 2002, Creadev has invested over €1.8 Bn in companies in stages ranging from venture to growth equity and buyout.

About Alira Health:

Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare. We work with healthcare and life sciences organizations looking for support across their entire solutions lifecycle. From development to medical care, we complement our clients’ expertise with a full spectrum of services including research and clinical development solutions, technology-powered consulting, and real-world evidence.

Our integrated and multidisciplinary team of over 500 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50% of MedTech companies and 50% of the top 50% of Pharma companies.

Learn more at https://www.alirahealth.com/ .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kemwell Biopharma Facility in Bengaluru Successfully Completes U.S. FDA Inspection for Commercial Drug-Product Manufacturing28.10.2025 07:00:00 CET | Press release

Milestone expands India’s role in global biologics manufacturing; collaboration with Cipla underscores commitment to quality and reliability Kemwell Biopharma Pvt Ltd (“Kemwell”), a leading global biologics Contract Development and Manufacturing Organization (CDMO), announced today that its drug-product manufacturing facility in Bengaluru has successfully completed a U.S. Food and Drug Administration (FDA) pre-approval inspection (PAI) and is now cleared for the commercial manufacturing and testing of injectable products destined for the U.S. market. This milestone marks the approval of the first product to get U.S. FDA clearance for commercial supply from Kemwell’s Bengaluru drug-product facility since the site became a dedicated biologics campus eight years ago. It demonstrates the company’s ability to meet stringent current Good Manufacturing Practice (cGMP) and aseptic drug-product manufacturing standards. “Achieving FDA clearance for commercial manufacturing from our Bengaluru sit

Uzbekistan's National Payment System HUMO and Ant International’s Alipay+ Partner to Facilitate Cross-Border QR Payments28.10.2025 06:55:00 CET | Press release

HUMO will be the 10th national QR network to partner with Alipay+, enabling its network of Uzbek digital payment apps to make cross-border QR payments across Alipay+’s global merchant ecosystem.The Octomobile app by Octobank, supported by HUMO, will be the first Uzbek e-wallet to be integrated with Alipay+, with more Uzbek e-wallets expected to join by the end of the year.Alipay+ now partners with 40 e-wallets and bank apps and 10 national QR payment schemes and payment systems worldwide, connecting over 100 million merchants to 1.8 billion consumers accounts. Alipay+, Ant International’s global wallet gateway, and HUMO, the national payment system in Uzbekistan, announced the partnership in Beijing to facilitate inbound and outbound cross-border QR payments. The Octomobile app by Octobank will be the first Uzbek e-wallet integrated with Alipay+, with more HUMO-connected local e-wallets and bank apps expected to join by the end of the year. This press release features multimedia. View

e.l.f. Beauty Releases FY2025 Impact Report with Emphasis on ‘the Every’28.10.2025 05:01:00 CET | Press release

Bold new campaign encourages the community to “give an e.l.f.” and join the company in making the world a better place for every eye, lip and face e.l.f. Beauty (NYSE: ELF), a purpose-led, results-driven company on a mission to make the best of beauty accessible to every eye, lip and face, today released its fourth annual Impact Report. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251027352775/en/ e.l.f. Beauty releases 4th annual Impact Report, emphasizing it’s evolved purpose statement: to make the world a better place for every eye, lip and face. The digital-first report is built around the theme of “the every”— a reflection of e.l.f.’s commitment to be a bold disruptor with a kind heart. To amplify the message behind the Impact Report, e.l.f. also launched a bold, international consumer campaign: “Give an e.l.f.” The campaign features voices of kindred spirits and encourages the community to fuel their own sense of pur

Geoswift Integrates with Circle Payments Network to Offer Stablecoin-Powered Real-Time Settlements in Cross-Border Payments28.10.2025 00:04:00 CET | Press release

Geoswift, a leading provider of cross-border payment services and solutions globally, today announced its integration with Circle Payments Network (CPN). Geoswift integrates its banking infrastructure with stablecoin-powered settlement system, enabling real-time, compliant, and cost-efficient B2B payments worldwide. Building on its role as an Originating Financial Institution (OFI) within CPN, Geoswift enables clients to expand into Latin America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251024721293/en/ Raymond Qu, Group CEO and founder of Geoswift, and Sunil Sharma, VP Product Management at Circle, celebrating the partnership in Las Vegas. “Geoswift has built a trusted track record in delivering secure, compliant settlements across Asia Pacific, North America, Europe, and the Middle East. By joining Circle Payments Network, we are modernizing that global reach with real-time stablecoin infrastructure — creating faste

Thredd Enters the Credit Space Partnering with LoanPro to Power Next-Generation Credit Capabilities27.10.2025 22:00:00 CET | Press release

Partnership joins LoanPro’s modern lending and credit capabilities with Thredd’s global card issuance and processing to offer scalable and compliant credit solutions across the U.S. and beyond Thredd, the leading next-generation global payments processor, today announced its selection of LoanPro, the modern credit platform, to underpin Thredd’s new suite of credit solutions for fintechs and financial organizations. The partnership marks a significant milestone in Thredd’s strategy to deliver full-stack embedded issuing and processing capabilities inclusive of credit, debit and prepaid. By integrating LoanPro’s advanced, composable credit infrastructure with Thredd’s next gen real-time card issuance and processing capabilities, including digital wallets and embedded fraud detection, clients will be able to design, launch and scale differentiated credit products with unprecedented speed and personalization. The collaboration leverages LoanPro’s category-leading expertise in powering inno

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye